Best Practice & Research Clinical Haematology
Volume 20, Issue 3 , Pages 363-365, September 2007

Introduction: Chronic lymphocytic leukemia in perspective

  • Kanti R. Rai, MD (Chief, Division of Hematology-Oncology, Long Island Jewish Medical Center, New Hyde Park, NY, and Joel Finkelstein Cancer Foundation Professor of Medicine, Albert Einstein College of Medicine, Bronx, NY)

      Affiliations

    • Corresponding Author InformationTel.: +1 718 470 7135; Fax: +1 718 347 6073.

Division of Hematology-Oncology, Long Island Jewish Med Center, New Hyde Park, NY 11040, USA

Although during the past two decades there has been considerable progress in our understanding of the pathophysiology of chronic lymphocytic leukemia (CLL) and in our ability to treat this disease, actual integration of the newly identified pathophysiological mechanisms has not occurred. This perspective essay identifies some of the questions which deserve to be addressed by clinicians and scientists involved in the study of CLL. The most important unresolved remaining issue, however, is the need for standardization of tests performed by commercial labs to assure the reliability and reproducibility of results of ZAP-70, CD38, IgVH gene mutation status and fluorescence in-situ hybridization (FISH) cytogenetics.

Key words: ZAP-70, CD38, FISH cytogenetics, Ig gene mutation, reliability of testing

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6926(07)00045-X

doi:10.1016/j.beha.2007.03.008

Best Practice & Research Clinical Haematology
Volume 20, Issue 3 , Pages 363-365, September 2007